China may approve first Covid-19 drug within weeks
- Monoclonal antibody treatment developed by Chinese and US researchers might get conditional approval by year-end, science and technology ministry daily says
- Sinopharm subsidiary meanwhile is readying clinical trials for both human and lab-made antibody treatments
Corrected [1:28pm, 17 Nov, 2021]
- [1:28pm, 17 Nov, 2021]
An earlier version of this story incorrectly reported that Brii Bio was seeking conditional approval for its drug in China. The story has been amended to reflect that a company spokeswoman did not specify what kind of approval was sought.